ID | 672 |
No | 672 |
Brand Name | MONTAIR TABLET 5 MG |
Ingredients | MONTELUKAST SODIUM EQ.TO MONTELUKAST 5 MG |
Dosage Form | CHEWABLE TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 2 years |
Pack Size | BOX OF 2 X 7'S |
Dispensing Category | Prescription only |
ATC Classification | XX |
Pharmaceutical Class | LEUKOTRIEN RECEPTOR ANTAGONIST |
Indications | TREATMENT OF ASTHMA AS ADD-ON THERAPY IN THOSE 2-5 YEAR-OLD PATIENTS WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA.
PROPHYLAXIS OF ASTHMA FROM 2 YEARS OF AGE AND OLDER IN WHICH THE PREDOMINANT COMPONENT IS EXCERCISED-INDUCED BRONCHOCONSTRICTION.
|
Contraindications | HYPERSENSITIVITY |
Side Effects | HEADACHE, INSOMNIA, ABDOMINAL PAIN, DIARRHEA, NAUSEA, VOMITING |
Unit Price | |
EDL |
Yes |
Description | LIGHT CHOCOLATE BROWN COLORED ROUND BICONVEX SHAPED TABLETS |
Note | |
License Owner | EXAMED CO.,LTD |
Manufacturer | CCL PHARMACEUTICALS (PVT.) LTD. |
Country | PAKISTAN |
Import Registration No | 29951 |
Import Registration Date | 2007-04-16 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-11-11 |
FDD Registration No | 08 I 5593/23 |
FDD Registration Date | 2023-09-05 |
Expiry Date | 2026-09-04 |